The treatment of malaria in glucose-6-phosphate dehydrogenase deficient patients in Sabah.
D000293:Adolescent; D000328:Adult; D000743:Anemia, Hemolytic / Q000139:chemically induced; D000962:Antimalarials / Q000627:therapeutic use; D002648:Child; D002738:Chloroquine / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications*; D006801:Humans; D008288:Malaria / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011319:Primaquine / Q000009:adverse effects / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use
D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D011319:Primaquine; D011739:Pyrimethamine